Log in to save to my catalogue

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003366

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

About this item

Full title

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

Publisher

Turkey: Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health)

Journal title

Türk psikiyatri dergisi, 2024-01, Vol.35 (1), p.1-7

Language

English

Formats

Publication information

Publisher

Turkey: Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health)

More information

Scope and Contents

Contents

It is known that inflammation plays a role in the etiopathogenesis of schizophrenia. In this study, we examined high mobility group box 1 protein (HMGB1) and Beclin 1 levels and their relationship with clinical variables in patients with schizophrenia.
Forty-three patients with schizophrenia and 43 healthy controls were included in this study. T...

Alternative Titles

Full title

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003366

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003366

Other Identifiers

ISSN

1300-2163

E-ISSN

2651-3463

DOI

10.5080/u27030

How to access this item